This document discusses vector control research needs for neglected tropical diseases. It identifies several challenges with current vector control efforts, including lack of resources, delays in implementation, and lack of routine surveillance. It also discusses knowledge gaps around dengue virus transmission and the impact of vector interventions. Key research areas are identified such as measuring entomological risk, assessing the epidemiological impact of control, and monitoring insecticide resistance. The document emphasizes the need for integrated vector management approaches and evaluating current tools and strategies to better understand their disease impact.
This research has developed recommendations for stakeholders involved in area-wide management of fruit fly, including social and institutional requirements.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
This research has developed recommendations for stakeholders involved in area-wide management of fruit fly, including social and institutional requirements.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
This Manual of Procedures (MOP) was developed to assist and align the efforts in implementing AMS programs in all (Level I, II, and III) hospitals across the country. It seeks to serve as a guide to individual hospitals in the design and establishment of local AMS programs while providing a framework for national-level action and commitment.
Recommendations within this document are, as far as possible, based on review of published literature on strategies that have shown to be effective. Consultation with key members (Infectious Diseases physicians, clinical pharmacists, and Infection Control nurses) from eight (8) pilot hospitals as well as the National Antibiotic Guidelines Committee (NAGCom), other national Infectious Diseases societies and relevant DOH offices were undertaken to obtain a consensus opinion and ensure that this MOP is practical and feasible.
All attempts to consider the context of local culture and practices have been taken in the creation of this MOP. Nonetheless, we have chosen to only define core aspects of the national AMS program without being overly prescriptive. Hospitals are strongly encouraged to adapt this MOP to their individual setting in order to maximize its effectiveness, including reduce barriers to implementation and encourage shared ownership towards the goal of AMS.
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health ExamplesJohn Blue
One Health Antibiotic Stewardship Human Health Examples - Dr. Dawn Sievert, Associate Director for Antimicrobial Resistance, Division of Foodborne, Waterborne, and Environmental Diseases, CDC; Dr. Edward J. Septimus, V.P. Research & Infectious Diseases, Hospital Corporation of America; Dr. Lauri Hicks, Director, Office of Antibiotic Stewardship, CDC, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Dr. Julie Lyn Hall, WHO Country Representative for the Philippines, discusses the strategies of the WPRO in handling and preventing EIDs like Ebola and MERS-CoV in our region
Infection Control and Antibiotic Stewardship Symposia presented in Milot, Haiti at Hôpital Sacré Coeur.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
Presented by Theo Knight-Jones and Lucy Robinson at the open session of the standing technical and research committees of the European Commission for the control of foot and mouth disease, Cavtat, Croatia, 29-31 October 2014.
Dengue is a severe life threatening, vector borne disease. It infects a big number of people every year. it is disease of urban or peri-urban areas. Aedes aegypti is the principal mosquito responsible for most of the disease outbreaks in world. Aedes albopictus is another common species reported as secondary vector in many parts of the world. It is well known as Asian tiger mosquito having white strips on entire body. Aedes aegypti is also vector of the yellow fever, chikungunya and zika virus disease.
In the absence of any frequently available potent vaccine, application of effective vector control interventions is the best solution. Evidence decision making is key to vector control operation that is based on carefully collected data obtained through comprehensive vector surveillance.
Dengue Vector Surveillance provides fundamental information for application of an appropriate vector control intervention. Vector surveillance and control are strongly interlinked, and vector surveillance loses its worth without utilization of information for appropriate vector control. In Pakistan dengue is endemic in all parts of the country. First epidemic of the disease was reported in 1994 from karachi, thereafter, regular outbreaks are being observed after every 3-5 years.
A basic introduction into the subject of health system preparedness for emerging and re-emerging infections, including the definitions of EIDs and preparedness, as well as, one of many conceptual frameworks for preparedness.
This Manual of Procedures (MOP) was developed to assist and align the efforts in implementing AMS programs in all (Level I, II, and III) hospitals across the country. It seeks to serve as a guide to individual hospitals in the design and establishment of local AMS programs while providing a framework for national-level action and commitment.
Recommendations within this document are, as far as possible, based on review of published literature on strategies that have shown to be effective. Consultation with key members (Infectious Diseases physicians, clinical pharmacists, and Infection Control nurses) from eight (8) pilot hospitals as well as the National Antibiotic Guidelines Committee (NAGCom), other national Infectious Diseases societies and relevant DOH offices were undertaken to obtain a consensus opinion and ensure that this MOP is practical and feasible.
All attempts to consider the context of local culture and practices have been taken in the creation of this MOP. Nonetheless, we have chosen to only define core aspects of the national AMS program without being overly prescriptive. Hospitals are strongly encouraged to adapt this MOP to their individual setting in order to maximize its effectiveness, including reduce barriers to implementation and encourage shared ownership towards the goal of AMS.
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health ExamplesJohn Blue
One Health Antibiotic Stewardship Human Health Examples - Dr. Dawn Sievert, Associate Director for Antimicrobial Resistance, Division of Foodborne, Waterborne, and Environmental Diseases, CDC; Dr. Edward J. Septimus, V.P. Research & Infectious Diseases, Hospital Corporation of America; Dr. Lauri Hicks, Director, Office of Antibiotic Stewardship, CDC, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Dr. Julie Lyn Hall, WHO Country Representative for the Philippines, discusses the strategies of the WPRO in handling and preventing EIDs like Ebola and MERS-CoV in our region
Infection Control and Antibiotic Stewardship Symposia presented in Milot, Haiti at Hôpital Sacré Coeur.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
Presented by Theo Knight-Jones and Lucy Robinson at the open session of the standing technical and research committees of the European Commission for the control of foot and mouth disease, Cavtat, Croatia, 29-31 October 2014.
Dengue is a severe life threatening, vector borne disease. It infects a big number of people every year. it is disease of urban or peri-urban areas. Aedes aegypti is the principal mosquito responsible for most of the disease outbreaks in world. Aedes albopictus is another common species reported as secondary vector in many parts of the world. It is well known as Asian tiger mosquito having white strips on entire body. Aedes aegypti is also vector of the yellow fever, chikungunya and zika virus disease.
In the absence of any frequently available potent vaccine, application of effective vector control interventions is the best solution. Evidence decision making is key to vector control operation that is based on carefully collected data obtained through comprehensive vector surveillance.
Dengue Vector Surveillance provides fundamental information for application of an appropriate vector control intervention. Vector surveillance and control are strongly interlinked, and vector surveillance loses its worth without utilization of information for appropriate vector control. In Pakistan dengue is endemic in all parts of the country. First epidemic of the disease was reported in 1994 from karachi, thereafter, regular outbreaks are being observed after every 3-5 years.
A basic introduction into the subject of health system preparedness for emerging and re-emerging infections, including the definitions of EIDs and preparedness, as well as, one of many conceptual frameworks for preparedness.
Zika Prevention Approaches in Jamaica UWI_Markcomm
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach for tackling the Zika virus.
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...John Blue
One Health Antibiotic Stewardship Science and Practice - What are the Major Gaps in Knowledge or Translation? How Do We Find the Answers to What We Don't Know? - Dr. Kerry Keffaber, Chief Veterinarian, Scientific Affairs and Policy, Elanco Animal Health; Dr. Jeff Bender, Professor, Environmental Sciences, University of Minnesota; Dr. Nora Schrag, Clinical Assistant Professor/Agricultural Practices, Kansas State University; Mr. Joe Swedberg, Chairman of the Board, Farm Foundation, Hormel Foods Corporation (retired); Dr. David G. White, Associate Dean for Research, University of Tennessee Institute of Agriculture, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Similar to Raman Velayudhan-Enfermedades transmitidas por vectores (20)
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
El jueves 24 de mayo del 2018 organizamos una Conferencia con Antonio Cabrales en la Fundación Ramón Areces. Una conferencia en la cual el tema fue: Estilo negociador y confianza, ¿hay diferencias entre hombres y mujeres?
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Fundación Ramón Areces
El lunes y martes 21 y 22 de mayo del 2018 realizamos un Simposio Internacional en la Fundación Ramón Areces, tratando el tema de la superconductividad y presión: una relación fructífera en el camino hacia la superconductividad a temperatura ambiente.
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Fundación Ramón Areces
El lunes y martes 21 y 22 de mayo del 2018 realizamos un Simposio Internacional en la Fundación Ramón Areces, tratando el tema de la superconductividad y presión: una relación fructífera en el camino hacia la superconductividad a temperatura ambiente.
El jueves 17 de mayo del 2018 se organizó una Mesa Redonda en la Fundación Ramón Areces, en la cual se habló sobre las subidas de tipos en la era Trump y la nueva globalización.
El jueves 17 de mayo del 2018 se organizó una Mesa Redonda en la Fundación Ramón Areces, en la cual se habló sobre las subidas de tipos en la era Trump y la nueva globalización.
El miércoles 16 de mayo del 2018 celebramos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre las nuevas fronteras de investigación sobre la distribución comercial y el comportamiento del consumidor.
El miércoles 16 de mayo del 2018 celebramos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre las nuevas fronteras de investigación sobre la distribución comercial y el comportamiento del consumidor.
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Fundación Ramón Areces
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Fundación Ramón Areces
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El viernes 27 de abril del 2018 se celebró en la Fundación Ramón Areces una Jornada sobre física , en la cual se trataron diversos temas como: Los materiales mecanocalóricos, magnetísmo, biofísica, la energía oscura y instrumentación astronómica.
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Fundación Ramón Areces
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Raman Velayudhan-Enfermedades transmitidas por vectores
1. Vector control research needs for NTDs
Dr Raman Velayudhan,
Coordinator,
Vector Ecology and Management, NTD
2. Challenges of Vector Control
Lack of resources
Very often used as a last resort
Equipment's and plans are developed after the outbreak is
underway
A delay of over a week makes control ineffective
Decentralization of health services
Trained staff
Procurement of appropriate interventions
Lack of routine vector surveillance
Urban vector control
Delivery/Responsibility
Community involvement
Often blamed for failure
4. Knowledge & Research Gaps for Dengue Vector
Control
• Why is disease burden increasing?
Unsuccessful programs: Lack of resources, lack of political will or
ineffective implementation
Also responsible: Deficiencies in understanding virus transmission,
methods for assessing & responding to risk & failure to effectively use
surveillance data for control decisions
Knowledge & research gaps:
• Entomological measures of risk
• Epidemiologic impact of vector interventions
• Insecticide resistance: monitor & manage
• Spatial scales that characterize transmission
• Dynamic responses to control
• Research design for VC
5. Urban, semi-urban and rural movement
• Human movement –
critical and understudied
component in
transmission
• Facilitate identification of
hot spots, prompt
response and suppress
outbreaks
• Surveillance, intervention
and prevention
• Points of entry needs to
be monitored for vectors
under IHR (2005)
6. A Critical Assessment of Vector Control
for Dengue Prevention
NL Achee, F Gould, TA Perkins, RC Reiner, Jr., AC
Morrison, S Richie, DJ Gubler, and TW Scott
7. HAT and vector
• Vector borne disease, transmitted by glossina genus (tsetse fly)
• Main species involved:
• Gambiense HAT: G. palpalis, G. fuscipes
• Rhodesiense HAT: G. morsitans, G. fuscipes, G. pallidipes, G. Swynnetoni
8. HAT vector control
• Multiple vector control methods available, to be adapted to different
epidemiological settings
Ground spraying
Aerial spraying
Sterile insects release
Mobile baits
Natural baits
Protective fences
Artificial baits
Repellents
9. Rhodesiense HAT and vector control
• Rhodesiense HAT is a zoonotic disease where wildlife and
domestic animals are the main reservoirs. Vector control
and treatment of infected animals when possible are key
elements for controlling the disease.
• Vector control has successfully used in some Rhodesian
HAT foci. Successes were achieved through large-scale
operations, expensive and requiring strong vector control
departments
• Current vector control tools are highly variable in
characteristics and quality (Fabrics, colors, insecticide
loading and release,…). Target product profiles of these
tools tailored to different environments are needed.
• It is needed to improve the evidence-based knowledge for
countries to make decisions on which tools to use in
different settings, and how to use them most effectively.
10. Elimination of intra-domiciliary vectorial transmission of Chagas disease
in Latin America (2020)
Control of vectorial
transmission by August 2015
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
WHO1960
WHO1976
WHO1981
PAHO1984
Walsh1984
WHO1985
WHO1990
WHO1991
WHO1992
PAHO1994
Schmunis1999
Schmunis1999
Schmunis2000
WorlBank/DCPP2006
PAHO/WHO2006
WHO2010
WHO2013
WHO2014
Series1
Latin
American
Initiatives
Non endemic coutries
Initiative
• 3 hot control areas remaining: Gran Chaco, El Salvador/Guatemala & Amazon basin
13. What tools/approaches are available for tackling exophilic
and exophagic sandflies?
1. Treating other main sources of bloodmeals with
systemic insecticides (endectocides), such as fipronil
and imidacloprid.
2. Exploiting sugar-feeding behaviour of vectors to
develop attractive toxic sugar baits (ATSBs)
3. Environmental Control
4. Developing insecticide-impregnated or repellent-
impregnated products to be used by specific
communities.
5. Pheromones?
6. Genetic Control? (e.g. SIT: sterile insect technique)
14. Integrated Vector Management
A rational decision-making process for
optimal use of resources for vector control
How do we operationalize IVM?
15. Framework for planning & implementation
2. Selection of
vector control
methods
3. Needs &
resources
4. Implementation
5. Monitoring
& evaluation
Disease situation
• Integrated surveillance
Vector, cases, lab
• Vector assessment
• Epidemiological assessment
• Stratification
• Local determinants of disease
Diseases specific
reporting needs
16. Conclusion
Current tools & strategies have not been evaluated
adequately for disease impact (epidemiologic outcomes)
There is current research on new tools/strategies, but little
support for improving delivery & coverage of vector control
The biggest gap in current vector control for is how much
coverage is necessary for disease reduction goals
General consensus is that 1 approach will not solve the
problem by itself, we need to use a combination of
approaches
Vector control & vaccines: How exactly should this be done?
Urban health and delivery of services needs to be addressed
Sustained vector control interventions needs to be promoted